Medical Genetics, Department of Precision Medicine, Università degli Studi della Campania 'Luigi Vanvitelli', Via Luigi De Crecchio 7, 80138, Naples, Italy.
Multidisciplinary Department of Medical, Surgical and Dental Sciences, Eye Clinic, Università degli Studi della Campania 'Luigi Vanvitelli', Via Pansini 5, 80131, Naples, Italy.
Sci Rep. 2022 Dec 2;12(1):20815. doi: 10.1038/s41598-022-24636-1.
Inherited retinal diseases (IRDs) are the leading cause of vision loss in the working-age population. We performed a retrospective epidemiological study to determine the genetic basis of IRDs in a large Italian cohort (n = 2790) followed at a single referral center. We provided, mainly by next generation sequencing, potentially conclusive molecular diagnosis for 2036 patients (from 1683 unrelated families). We identified a total of 1319 causative sequence variations in 132 genes, including 353 novel variants, and 866 possibly actionable genotypes for therapeutic approaches. ABCA4 was the most frequently mutated gene (n = 535; 26.3% of solved cases), followed by USH2A (n = 228; 11.2%) and RPGR (n = 102; 5.01%). The other 129 genes had a lower contribution to IRD pathogenesis (e.g. CHM 3.5%, RHO 3.5%; MYO7A 3.4%; CRB1 2.7%; RPE65 2%, RP1 1.8%; GUCY2D 1.7%). Seventy-eight genes were mutated in five patients or less. Mitochondrial DNA variants were responsible for 2.1% of cases. Our analysis confirms the complex genetic etiology of IRDs and reveals the high prevalence of ABCA4 and USH2A mutations. This study also uncovers genetic associations with a spectrum of clinical subgroups and highlights a valuable number of cases potentially eligible for clinical trials and, ultimately, for molecular therapies.
遗传性视网膜疾病(IRDs)是导致工作年龄人群视力丧失的主要原因。我们进行了一项回顾性流行病学研究,以确定在一个单一转诊中心接受治疗的大型意大利队列(n=2790)的 IRD 的遗传基础。我们通过下一代测序为 2036 名患者(来自 1683 个无关家庭)提供了主要的、可能具有结论性的分子诊断。我们总共在 132 个基因中发现了 1319 个致病序列变异,包括 353 个新变异,以及 866 个可能用于治疗方法的可操作基因型。ABCA4 是突变最频繁的基因(n=535;已解决病例的 26.3%),其次是 USH2A(n=228;11.2%)和 RPGR(n=102;5.01%)。其他 129 个基因对 IRD 发病机制的贡献较低(例如,CHM 3.5%,RHO 3.5%;MYO7A 3.4%;CRB1 2.7%;RPE65 2%,RP1 1.8%;GUCY2D 1.7%)。78 个基因在 5 名或更少的患者中发生突变。线粒体 DNA 变异占病例的 2.1%。我们的分析证实了 IRDs 的复杂遗传病因,并揭示了 ABCA4 和 USH2A 突变的高流行率。这项研究还揭示了与一系列临床亚组的遗传关联,并强调了大量可能有资格参加临床试验,最终有资格接受分子治疗的病例。